The Ayurveda Experience spends Rs 248 Cr on advertising for Rs 440 Cr revenue in FY25

The Ayurveda Experience, a direct-to-consumer (D2C) brand focused on Ayurvedic beauty and wellness products, continued its growth trajectory in FY25 with a decent rise in revenue, though the company remained in the red due to high advertising and fulfillment costs.

The company’s operating revenue grew 23% to Rs 440 crore in FY25 from Rs 358 crore in FY24, according to its financial statements sourced from the Registrar of Companies (RoC).

The sale of products across its own platform and international marketplaces is the sole source of revenue for Ayurveda Experience. It also added Rs 8 crore from interest income, tallying the total revenue to Rs 448 crore during the fiscal year, up from Rs 361 crore in FY24.

On the cost side, advertising and promotional expenses continued to dominate its cost structure, forming over 52% of total expenses, which rose 24% to Rs 248 crore during FY25. Order fulfilment costs grew 30% to Rs 78 crore, while employee benefit expenses rose 37% to Rs 56 crore. The cost of materials inched up marginally by 3% to Rs 37 crore.

Overall, the firm’s total expenditure increased 23% to Rs 476 crore in FY25 from Rs 386 crore in FY24. For a more detailed expense breakup, refer to TheKredible.

The company’s expenses outpaced revenue growth, which resulted in the company’s losses increasing by 12% to Rs 28 crore in FY 25 from Rs 25 crore in FY24. Its ROCE and EBITDA margin stood at -22.09% and -7.50% respectively.

On a unit basis, The Ayurveda Experience spent Rs 1.08 to earn a rupee of operating revenue in FY25, similar to the previous year. The company’s current assets stood at Rs 164 crore, including cash and bank balances of Rs 57 crore at the end of March 2025.

According to startup data intelligence platform TheKredible, The Ayurveda Experience has raised a total of $41 million in funding to date, with Fireside Ventures and Anicut Capital as its lead investors. The company’s founder, Rishabh Chopra, owns 27.45% of the company.

The company seems well placed to turn a profit by FY27, even as it has to contend with an increasingly cluttered market linked to the ayurveda and wellness movement taking root in relevant pockets of India and international markets. The high promotional expenses are a red flag, considering the case for significant word of mouth or brand recall in a category like ayurveda, where product usage  is a clear statement of lifestyle choices and ‘against’ say other ‘chemical’ options available. Assuming a similar growth trajectory, the Rs 500 crore mark should be crossed in FY 26, a key milestone that will be a magnet for firms interested in acquiring businesses in the sector. Thus, investors in the Ayurveda experience will still have hopes that a profitable exit is not as unlikely, or as long a wait away as it might have seemed a couple of years ago.